Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer

Walker, Hayley; Rosenberg, Shoshana M.; Stanton, Annette L.; Petrie, Keith J.; Partridge, Ann H.

doi:10.1089/jayao.2015.0051

Cited by 30 publications

(29 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We found that women under age 50 were less likely to be adherent to ET. These findings are consistent with the literature on ET usage [8], which suggests that younger women have unique considerations in their ET decision-making framework, including fertility [20] and reluctance to believe ET was a necessary part of their breast cancer treatment [21]. These explanatory factors are not fully understood and warrant further research [22].…”

Section: Resultssupporting

confidence: 77%

Endocrine therapy use in the twenty-first century: usage rates and temporal trends illustrate opportunities for improvement for South Carolina Medicaid women

Bedi

Mayo

Truong

et al. 2018

Breast Cancer Res Treat

View full text Add to dashboard Cite

show abstract

Section: Resultssupporting

confidence: 77%

Endocrine therapy use in the twenty-first century: usage rates and temporal trends illustrate opportunities for improvement for South Carolina Medicaid women

Bedi

Mayo

Truong

et al. 2018

Breast Cancer Res Treat

View full text Add to dashboard Cite

show abstract

“…Women who were high risk were more likely to report being nonadherent. 42 Negative and positive emotions regarding therapy were related to decreased and increased adherence, respectively, 35 , 68 and perceived importance of therapy was related to increased adherence. 61 Karmakar 69 found that coping appraisal, defined as the effectiveness of taking HT and self-efficacy in ability to take HT, minus the costs of taking HT, was associated with increased odds of adherence.…”

Section: Resultsmentioning

confidence: 99%

“…Four studies found no effects of necessity beliefs on adherence. 27 , 40 , 46 , 68 These four studies had small sample sizes and may have lacked power to find a significant effect. However, where effect sizes were given, they were relatively small.…”

Section: Resultsmentioning

confidence: 99%

Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review

Moon

Moss‐Morris²,

Hunter³

et al. 2017

PPA

119

207

View full text Add to dashboard Cite

PurposeNonadherence to hormone therapy in breast cancer survivors is common and associated with increased risk of mortality. Consistent predictors of nonadherence and nonpersistence are yet to be identified, and little research has examined psychosocial factors that may be amenable to change through intervention. This review aimed to identify predictors of nonadherence and nonpersistence to hormone therapy in breast cancer survivors in order to inform development of an intervention to increase adherence rates.MethodsStudies published up to April 2016 were identified through MEDLINE, Embase, Web of Science, PsycINFO, CINAHL and gray literature. Studies published in English measuring associations between adherence or persistence and any predictor variables were included. Eligible studies were assessed for methodological quality, data were extracted and a narrative synthesis was conducted.ResultsSixty-one eligible articles were identified. Most studies focused on clinical and demographic factors with inconsistent results. Some evidence suggested that receiving specialist care and social support were related to increased persistence, younger age and increased number of hospitalizations were associated with nonadherence, and good patient–physician relationship and self-efficacy for taking medication were associated with better adherence. A small amount of evidence suggested that medication beliefs were associated with adherence, but more high-quality research is needed to confirm this.ConclusionSome psychosocial variables were associated with better adherence and persistence, but the results are currently tentative. Future high-quality research should be carried out to identify psychosocial determinants of nonadherence or nonpersistence that are modifiable through intervention.

show abstract

“…We have tried to explain this result as an indirect effect of depression with ET-specific factors, since the effects of self-efficacy and medication beliefs on medication adherence are known. High self-efficacy, high positive beliefs on medication, and low negative beliefs on medication are more likely to lead to adherence to prescribed medications [ 5 , 11 , 30 ]. Several studies which focused on self-efficacy and medication beliefs as mediators linking depression and medication adherence.…”

Section: Discussionmentioning

confidence: 99%

“…To the best of our knowledge, these efforts have mainly focused on identifying determinants of AET adherence. Few studies have addressed the relationships among the factors [ 6 , 30 ]. We designed a research framework based on the hierarchical model of AET adherence determinants [ 8 ] and a determinants of adherence model that was developed for dyspepsia medication [ 12 ].…”

Section: Discussionmentioning

confidence: 99%

Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer

Lee

Min

2018

BMC Women's Health

View full text Add to dashboard Cite

BackgroundInterventions that promote adjuvant endocrine therapy (AET) adherence are critical to improve breast cancer survival. The development of interventions would benefit from a better understanding of the reasons for adherence and the causal relationships of determinants using theoretical or model approaches. The aim of the present study was to identify reasons for AET adherence in breast cancer patients with sequential relationships and inter-relationships.MethodsA total of 210 participants with estrogen receptor positive breast cancer who received AET completed a questionnaire assessing demographic/medical, psychological, and endocrine therapy (ET)-specific factors. A descriptive analysis was performed to identify meaningful variables. Selected variables were subjected to hierarchical regression and path analyses. The path model was tested and modified based on the research framework and the results of regression weights and model fit.ResultsAnalysis of sequential effects showed that ET-specific factors contributed the largest proportion of variance (13.4%) to predict AET adherence, followed by psychological factors (4.6%) and demographic/medical factors (3.1%). Analysis of inter-relationships showed that demographic/medical factors such as AET regimen type and cancer stage have direct effects on AET adherence, whereas psychological factors contribute indirectly through the mediating effects of ET-specific factors.ConclusionAssessments and interventions that encompass the patient’s medication beliefs, self-efficacy, and depression are needed to promote AET adherence.

show abstract

Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer

Cited by 30 publications

References 35 publications

Endocrine therapy use in the twenty-first century: usage rates and temporal trends illustrate opportunities for improvement for South Carolina Medicaid women

Endocrine therapy use in the twenty-first century: usage rates and temporal trends illustrate opportunities for improvement for South Carolina Medicaid women

Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review

Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer

Contact Info

Product

Resources

About